Kamada is a biopharmaceutical company developing, producing and marketing a line of specialty, life-saving therapeutics using a sophisticated chromatographic purification technology. Utilizing its proprietary know-how, Kamada manufactures more than 10 high quality and highly safe biopharmaceuticals.
Founded in 1990, Kamada successfully completed an Initial Public Offering in 2005, and is now traded at the Tel Aviv Stock Exchange (KMDA). Over the years, Kamada has established a prominent presence within Israel’s distinguished pharmaceutical industry community.
Kamada’s mission is to develop, produce and manufacture high quality pharmaceuticals to enable better quality of life and to save lives.
.
